Home Cart Sign in  
Chemical Structure| 39149-80-9 Chemical Structure| 39149-80-9

Structure of 39149-80-9

Chemical Structure| 39149-80-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 39149-80-9 ]

CAS No. :39149-80-9
Formula : C7H13BrO2
M.W : 209.08
SMILES Code : CC(Br)C(OC(C)(C)C)=O
MDL No. :MFCD00043897
InChI Key :CVAWKJKISIPBOD-UHFFFAOYSA-N
Pubchem ID :545327

Safety of [ 39149-80-9 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P301+P312-P302+P352-P304+P340-P305+P351+P338

Computational Chemistry of [ 39149-80-9 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 0
Fraction Csp3 0.86
Num. rotatable bonds 3
Num. H-bond acceptors 2.0
Num. H-bond donors 0.0
Molar Refractivity 44.96
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

26.3 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.47
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.29
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.11
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.12
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.64
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.13

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.38
Solubility 0.87 mg/ml ; 0.00416 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.48
Solubility 0.693 mg/ml ; 0.00331 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.07
Solubility 1.76 mg/ml ; 0.00843 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.95 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.29

Application In Synthesis of [ 39149-80-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 39149-80-9 ]

[ 39149-80-9 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 64-65-3 ]
  • [ 39149-80-9 ]
  • [ 129224-48-2 ]
  • 2
  • [ 39149-80-9 ]
  • [ 2051-99-2 ]
  • (S)-tert-butyl 2-(4-isobutylphenyl)propanoate [ No CAS ]
  • C17H26O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
General procedure: To a 50-mL two-neck round-bottom flask equipped with a cannula were added magnesium turnings (608 mg, 25 mmol), and the flask was heated at 80 C in vacuo for 1 h. A solution of the <strong>[2051-99-2]4-isobutylphenyl bromide</strong> (426 mg, 2.0 mmol) in THF (5 mL) was added dropwise over 3 min under argon. The mixture was heated at 50 C until the reaction was initiated. Additional <strong>[2051-99-2]4-isobutylphenyl bromide</strong> (1.71 g, 8.0 mmol) in THF (11.6 mL) was then added slowly via cannula over 15 min. The reaction mixture was heated at reflux for 3 h, after which a solution of 4-isobutylphenyl magnesium bromide 5 was obtained. To a separate 50-mL Schlenk tube was added anhydrous CoBr2 (21.9mg, 0.10mmol), and the tube was heated at 50C in vacuo for 2h. After cooling to room temperature, the cyclopropane-based bisoxazoline ligand 2 (0.12mmol) in THF (3mL) was added under argon. The resulting mixture was stirred for 1h at the same temperature, with 2-bromopropanoate 6 (1mmol) being added via syringe. The mixture solution was cooled to -80C, and the prepared Grignard reagent 5 (2.8mL, 0.5M in THF, 1.4mmol) was then added over 1h via syringe. The reaction mixture was stirred for another 6h at -80C and then quenched with saturated NH4Cl solution (5mL). The aqueous phase was extracted with diethyl ether (4×10mL). The combined organic phases were dried over anhydrous Na2SO4, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (n-hexane/ethyl acetate 100:1). 4.4.4 (S)-tert-Butyl 2-(4-isobutylphenyl)propanoate 7d Colorless oil, 84% yield, 78:22 er. The enantiomeric ratio was determined by HPLC with a Daicel Chiralcel OJ-H column (0.3% 2-propanol in n-hexane, 0.5 mL/min, 220 nm, minor tr = 8.76 min (R), major tr = 11.17 min (S)). [alpha]D20 = +5.5 (c 1.2, CHCl3). 1H NMR (300 MHz, CDCl3) delta: 7.20-7.17 (m, 2H), 7.07 (d, J = 8.2 Hz, 2H), 3.58 (q, J = 7.2 Hz, 1H), 2.44 (d, J = 7.2 Hz, 2H), 1.89-1.80 (m, 1H), 1.43 (d, J = 7.2 Hz, 3H), 1.39 (s, 9H), 0.89 (d, J = 6.6 Hz, 6H). 13C NMR (75 MHz, CDCl3) delta: 174.0, 140.1, 138.3, 129.1, 127.0, 80.2, 46.1, 45.0, 30.1, 27.9, 22.3, 18.4. HRMS (APCI-TOF): calcd for C17H25O2 [M-H]- 261.1855, found 261.1842.
  • 3
  • [ 39149-80-9 ]
  • [ 256652-04-7 ]
  • [ 1334591-50-2 ]
  • C17H20O2 [ No CAS ]
  • 4
  • [ 864772-18-9 ]
  • [ 39149-80-9 ]
  • C19H22O3 [ No CAS ]
  • C19H22O3 [ No CAS ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 39149-80-9 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 535-11-5

A179596 [535-11-5]

Ethyl 2-bromopropionate

Similarity: 0.88

Chemical Structure| 5445-17-0

A736627 [5445-17-0]

Methyl 2-bromopropanoate

Similarity: 0.84

Chemical Structure| 1381861-91-1

A116954 [1381861-91-1]

tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate

Similarity: 0.80

Chemical Structure| 685-87-0

A971976 [685-87-0]

Diethyl 2-bromomalonate

Similarity: 0.80

Chemical Structure| 23426-63-3

A399099 [23426-63-3]

Methyl 2-bromo-2-methylpropanoate

Similarity: 0.80

Bromides

Chemical Structure| 535-11-5

A179596 [535-11-5]

Ethyl 2-bromopropionate

Similarity: 0.88

Chemical Structure| 5445-17-0

A736627 [5445-17-0]

Methyl 2-bromopropanoate

Similarity: 0.84

Chemical Structure| 1381861-91-1

A116954 [1381861-91-1]

tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate

Similarity: 0.80

Chemical Structure| 685-87-0

A971976 [685-87-0]

Diethyl 2-bromomalonate

Similarity: 0.80

Chemical Structure| 23426-63-3

A399099 [23426-63-3]

Methyl 2-bromo-2-methylpropanoate

Similarity: 0.80

Esters

Chemical Structure| 535-11-5

A179596 [535-11-5]

Ethyl 2-bromopropionate

Similarity: 0.88

Chemical Structure| 5445-17-0

A736627 [5445-17-0]

Methyl 2-bromopropanoate

Similarity: 0.84

Chemical Structure| 1381861-91-1

A116954 [1381861-91-1]

tert-Butyl 3-(2-(2-bromoethoxy)ethoxy)propanoate

Similarity: 0.80

Chemical Structure| 685-87-0

A971976 [685-87-0]

Diethyl 2-bromomalonate

Similarity: 0.80

Chemical Structure| 23426-63-3

A399099 [23426-63-3]

Methyl 2-bromo-2-methylpropanoate

Similarity: 0.80